Other Assets, Noncurrent in USD of REGENERON PHARMACEUTICALS, INC. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Regeneron Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and change rate from Q2 2010 to Q3 2025.
  • Regeneron Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $1.67B, a 60.4% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

REGENERON PHARMACEUTICALS, INC. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.67B +$630M +60.4% 30 Sep 2025 10-Q 28 Oct 2025
Q2 2025 $1.54B +$543M +54.6% 30 Jun 2025 10-Q 01 Aug 2025
Q1 2025 $1.39B +$923M +196% 31 Mar 2025 10-Q 29 Apr 2025
Q4 2024 $1.14B +$692M +156% 31 Dec 2024 10-Q 28 Oct 2025
Q3 2024 $1.04B +$633M +154% 30 Sep 2024 10-Q 31 Oct 2024
Q2 2024 $994M +$601M +153% 30 Jun 2024 10-Q 01 Aug 2024
Q1 2024 $470M +$121M +34.5% 31 Mar 2024 10-Q 02 May 2024
Q4 2023 $444M +$108M +32% 31 Dec 2023 10-K 05 Feb 2025
Q3 2023 $410M +$89.7M +28% 30 Sep 2023 10-Q 02 Nov 2023
Q2 2023 $393M +$123M +45.7% 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $350M +$87.6M +33.4% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $336M +$120M +55.7% 31 Dec 2022 10-K 05 Feb 2024
Q3 2022 $320M +$174M +119% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $270M +$127M +88.9% 30 Jun 2022 10-Q 03 Aug 2022
Q1 2022 $262M +$116M +79.8% 31 Mar 2022 10-Q 04 May 2022
Q4 2021 $216M +$48M +28.6% 31 Dec 2021 10-K 06 Feb 2023
Q3 2021 $146M -$22.9M -13.6% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $143M -$32.6M -18.6% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $146M -$15.5M -9.62% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $168M +$23.4M +16.2% 31 Dec 2020 10-K 07 Feb 2022
Q3 2020 $169M +$30.9M +22.4% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $176M +$35.7M +25.5% 30 Jun 2020 10-Q 05 Aug 2020
Q1 2020 $161M +$16.9M +11.7% 31 Mar 2020 10-Q 05 May 2020
Q4 2019 $145M +$17.3M +13.6% 31 Dec 2019 10-K 08 Feb 2021
Q3 2019 $138M +$12.7M +10.1% 30 Sep 2019 10-Q 05 Nov 2019
Q2 2019 $140M +$54.1M +63.2% 30 Jun 2019 10-Q 06 Aug 2019
Q1 2019 $144M +$65.3M +82.7% 31 Mar 2019 10-Q 07 May 2019
Q4 2018 $127M +$49.5M +63.5% 31 Dec 2018 10-K 07 Feb 2020
Q3 2018 $125M +$88.6M +242% 30 Sep 2018 10-Q 06 Nov 2018
Q2 2018 $85.7M +$48.7M +132% 30 Jun 2018 10-Q 02 Aug 2018
Q1 2018 $79M +$41.9M +113% 31 Mar 2018 10-Q 03 May 2018
Q4 2017 $77.9M +$57.6M +284% 31 Dec 2017 10-K 07 Feb 2019
Q3 2017 $36.6M +$15.9M +76.9% 30 Sep 2017 10-Q 08 Nov 2017
Q2 2017 $37M +$30.2M +450% 30 Jun 2017 10-Q 03 Aug 2017
Q1 2017 $37.1M +$31.3M +540% 31 Mar 2017 10-Q 04 May 2017
Q4 2016 $20.3M +$14.5M +249% 31 Dec 2016 10-K 08 Feb 2018
Q3 2016 $20.7M +$16.1M +352% 30 Sep 2016 10-Q 04 Nov 2016
Q2 2016 $6.72M +$2.58M +62.3% 30 Jun 2016 10-Q 04 Aug 2016
Q1 2016 $5.79M +$1.32M +29.5% 31 Mar 2016 10-Q 05 May 2016
Q4 2015 $5.81M +$2.78M +91.5% 31 Dec 2015 10-K 09 Feb 2017
Q3 2015 $4.58M +$1.17M +34.2% 30 Sep 2015 10-Q 04 Nov 2015
Q2 2015 $4.14M -$4.74M -53.4% 30 Jun 2015 10-Q 04 Aug 2015
Q1 2015 $4.47M -$867K -16.2% 31 Mar 2015 10-Q 07 May 2015
Q4 2014 $3.03M -$2.29M -43% 31 Dec 2014 10-K 11 Feb 2016
Q3 2014 $3.42M -$993K -22.5% 30 Sep 2014 10-Q 04 Nov 2014
Q2 2014 $8.88M -$6.33M -41.6% 30 Jun 2014 10-Q 05 Aug 2014
Q1 2014 $5.34M -$14.7M -73.4% 31 Mar 2014 10-Q 08 May 2014
Q4 2013 $5.33M -$17.8M -76.9% 31 Dec 2013 10-K 12 Feb 2015
Q3 2013 $4.41M -$13.9M -75.9% 30 Sep 2013 10-Q 05 Nov 2013
Q2 2013 $15.2M -$4.36M -22.3% 30 Jun 2013 10-Q 06 Aug 2013
Q1 2013 $20.1M -$315K -1.55% 31 Mar 2013 10-Q 03 May 2013
Q4 2012 $23.1M +$16.9M +270% 31 Dec 2012 10-K 13 Feb 2014
Q3 2012 $18.3M +$5.3M +40.7% 30 Sep 2012 10-Q 24 Oct 2012
Q2 2012 $19.6M +$7.28M +59.3% 30 Jun 2012 10-Q 25 Jul 2012
Q1 2012 $20.4M +$10.2M +99.4% 31 Mar 2012 10-Q 26 Apr 2012
Q4 2011 $6.24M -$546K -8.04% 31 Dec 2011 10-K 15 Feb 2013
Q3 2011 $13M +$6.16M +89.8% 30 Sep 2011 10-Q 27 Oct 2011
Q2 2011 $12.3M +$5.59M +83.5% 30 Jun 2011 10-Q 28 Jul 2011
Q1 2011 $10.2M 31 Mar 2011 10-Q 03 May 2011
Q4 2010 $6.79M 31 Dec 2010 10-K 21 Feb 2012
Q3 2010 $6.86M 30 Sep 2010 10-Q 28 Oct 2010
Q2 2010 $6.7M 30 Jun 2010 10-Q 28 Jul 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.